In fact, like most biotech companies around the world that have pioneered new fields in the past decade, CHO Pharma has had a difficult time in the process.
Diamond Biofund’s excellent team and its successful experience in coaching companies has always provided timely assistance at critical moments, allowing me, who was originally focused on academic research but not familiar with the industry, to quickly identify a development blueprint that would allow CHO Pharma to play in the World Cup. This is the biggest difference between Diamond Biofund and most of the biomedical venture capitalists who only contribute capital. We believe that we will soon achieve our vision of becoming a global glycogen technology leader in biotechnology pharmaceuticals through continued support from Diamond Biofund.